Bio-Rad Labs (BIO) Tops Q2 EPS by 58c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $280.52 -0.68%
EPS Growth %: -30.7%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -30.7%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.38, $0.58 better than the analyst estimate of $2.80. Revenue for the quarter came in at $691.1 million versus the consensus estimate of $682.62 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Hermès can regain momentum despite China weakness, Jefferies says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
